Enliven Therapeutics to Host Webcast Conference Call to Discuss Phase 1 ELVN-001 Clinical Data Being Presented at EHA 2026 Congress
Go back to Enliven Therapeutics to Host Webcast Conference Call to Discuss Phase 1 ELVN-001 Clinical Data Being Presented at EHA 2026 Congress| (NASDAQ: ELVN) | Delayed: 46.32 +1.22 (2.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.10 | 52 Week High | $ | |||
| Open | $45.26 | 52 Week Low | $ | |||
| Day High | $48.52 | P/E | N/A | |||
| Day Low | $45.25 | EPS | $ | |||
| Volume | 1,377,744 | |||||

